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ABSTRACT 
Background: Although inflammation is a normal part of wound healing, if 
the inflammatory esponse is excessive the repair process might be prolonged. 
Nitric oxide (NO) has been implicated in healing inflammation and wounds. 
Objective: Endotoxins and cytokines associated with sepsis induce NO 
synthesis in the tissues. This study used tensile strength and tissue hydroxy- 
proline levels as proxies for wound healing to determine whether wound heal- 
ing in the presence of endotoxemia s improved when NO synthase is inhibit- 
ed by N-nitro-L-arginine methyl ester (L-NAME) or NS-(1-Imino-methyl)-L-ornithine 
(L-NIO). 
Methods: In this investigator-blinded, controlled, experimental study, male 
Wistar albino rats (275-300 g) were divided into 4 groups. The first group re- 
ceived an intraperitoneal (IP) injection of Escherichia coli endotoxin 10 mg/kg 
and an SC injection of 0.9% sodium cloride (NaCI). The second group received 
IP E coli 10 mg/kg and SC L-NAME 2 mg/kg. The third group received IP E coli 
10 mg/kg and L-NIO 10 mg/kg. The control group was administered an IP and 
an SC injection of 0.9% NaC1. Each group received both injections at 24 and 
16 hours before surgery. All rats underwent a 3-cm dorsal midline incision, 
which was subsequently closed. Five days after surgery, all rats were utha- 
nized and skin from the healing wound was excised. Hydroxyproline l vels and 
tensile strength were then measured. 
Results: Forty-four male rats (mean age, 16 weeks; mean [SD] weight, 284 [16] g) 
were included in the study. Each of the groups receiving endotoxin (endotoxin, 
L-NAME, and L-NIO groups) had 12 rats; the control group consisted of 8 rats. 
All the groups that received endotoxin showed significant declines in hydroxy- 
proline levels versus controls (P < 0.001, P-- 0.001, and P = 0.002, respectively). 
Compared with the control group, the endotoxin-only group had a significant 
reduction in both mean (SD) hydroxyproline l vels and mean (SD) wound 
tensile strength (298.27 [17.66] vs 175.82 [18.73] g/cm 2 and 7.16 [0.51] vs 4.01 
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[0.29] pg/mg wet tissue; both, P < 0.001). Compared with the endotoxin- 
only group, rats that received L-NIO had significantly greater mean (SD) 
hydroxyproline l vels and mean (SD) wound tensile strength (6.44 [0.34] vs 4.01 
[0.29] pg/mg wet tissue and 280.12 [14.38] vs 175.82 [18.73] g/cm2; both, P < 
0.001). Wound tensile strength in the L-NIO group was not significantly different 
from that in the control group. A significant difference was observed between 
the L-NIO and L-NAME groups in wound tensile strength (280.12 [14.38] vs 
241.38 [20.69] g/cm2; P = 0.001), but not in tissue hydroxyproline l vels. 
Conclusion: Inhibition of NO synthesis might improve wound tensile 
strength, which suggests a possible role for NO inhibitors in improved wound 
healing in the presence of endotoxemia. (Curr Ther Res Clin Exp. 2006;67:378-385) 
Copyright © 2006 Excerpta Medica, Inc. 
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wound healing. 
INTRODUCTION 
Wound healing depends on complex interactions between growth factors and 
cytokines. I Inflammation is a normal part of wound healing; however, if the 
inflammatory response is excessive, the repair process might be prolonged. 2,3 
Nitric oxide (NO), a short-lived free radical, has been implicated in both inflam- 
mation and wound healing. 4This molecule is produced by 2 isoforms of the en- 
zyme NO synthase (NOS): the constitutive calcium-dependent isoform (cNOS) and 
the inducible calcium-independent isoform (iNOS). cNOS is expressed under 
normal physiologic conditions. Endotoxemia induces the synthesis of iNOS. 
This form of the enzyme releases larger quantities of NO than cNOS ordinarily 
does; concentrations of NO may reach cytotoxic levels during sepsis or mu- 
cosal inflammation. 4-8 
Experimental models of incisional wound healing have been developed 
to mimic the situation in surgical patients. 6 A literature search conducted in 
MEDLINE was performed (English language; 1970-2006; key terms: nitric oxide 
synthase inhibitors, L-NIO, L-NAME, endotoxin, endotoxemia, wound healing, 
hydroxyproline, and tensile strength). Assessment of the collagen levels is gen- 
erally used to describe the healing rate. 3,7,9 Collagen is in a dynamic state of 
equilibrium, with slow turnover accelerated in the process of repair and 
regeneration. 2-4 Measurement of the collagen levels in the tissue of healing 
wounds is usually accomplished indirectly by determining the quantity of 
hydroxyproline, an amino acid that is abundant in collagen. 1°-13 Another way 
to determine healing of closed incisional wounds is by measuring tensile 
strength, a parameter that reflects the quality and speed of regeneration. 1°,14 
The gross measurement of wound strength has been found to correlate 
directly with the deposition of collagen in the subcutaneous layer of wounds. 
Strength and integrity of the tissue are ensured by collagen accumulation and 
cross-linking. 2 
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Given the roles of NO in inflammation and sepsis, NO synthesis might play a 
role in wound healing, particularly when sepsis is present. Two agents that 
inhibit the iNOS enzyme are N-nitro-L-arginine methyl ester (L-NAME), a rever- 
sible iNOS inhibitor, and NS-(1-Imino-methyl)-L-ornithine (L-NIO), an irreversi- 
ble iNOS inhibitor. 5,9 These compounds have been used in previous tudies of 
ischemia/reperfusion injury, apoptosis, angiogenesis, and modulation of super- 
oxide formation. 15-17 
The purpose of this study was to investigate whether the impairment ofwound 
healing due to endotoxemia c n be reversed by the use of L-NAME and L-NIO. 
MATERIALS AND METHODS 
Following approval of this investigator-blinded, controlled, experimental study 
by the ethics committee of Gazi University Medical School (Ankara, Turkey), 
44 male Wistar albino rats weighing 275 to 300 g were divided arbitrarily into 
4 groups. Animals were obtained from Gazi University Laboratory Animal 
Breeding and Experimental Research Center, Ankara, Turkey. The first group 
(endotoxin-only group) received intraperitoneal (IP) injections of Escherichia 
coli endotoxin 10 mg/kg (lipopolysaccharide serotype 026:B6, Sigma Chemical 
Company, Steinheim, Germany) to induce systemic sepsis and an SC injection 
of 0.9% sodium chloride (NaCI). The second group (L-NAME group) received IP 
E coli endotoxin 10 mg/kg and SC L-NAME 2 mg/kg (Sigma Chemical Company). 
The third group (L-NIO group) received 1P E coli endotoxin 10 mg/kg and SC 
L-NIO 10 mg/kg (Sigma Chemical Company). The control group received IP and SC 
injections of 0.9% NaC1. All injections were performed twice, at 24 and 16 hours 
before surgery. 
Each rat was anesthetized with an IM injection of ketamine 40 mg/kg and 
xylazine 2.5 mg/kg and then received a 3-cm dorsal midline incision that in- 
cluded the panniculus carnosus. The incisions were then closed with 5 inter- 
rupted sutures of 6/0 polypropylene (Ethicon, Edinburgh, United Kingdom). On 
the fifth day after surgery all rats were uthanized, the sutures were removed, 
and a 3-cm 2 section of skin centered on the healing wound was excised. Hydroxy- 
proline levels and tensile strength were then measured. 
Tensile Strength Analysis 
For tensile strength measurements, a 1-cm 2 wide strip transverse to the 
wound was cut from the middle of the section. Wound strips were placed imme- 
diately in phosphate-buffered saline and tensile strength measurements were 
made within 60 minutes of sample extraction. Tensile strength was measured 
using an MI-4300-I tensiometer (Instron Corporation, Canton, Massachusetts). 
The strips were subjected to uniaxial extension using a cross speed of 25 mm/min 
at a room temperature of 25°C and humidity of 45%. The weight at the time 
of wound breaking per area of the specimen was considered as the tensile 
strength of the wound (g/cm2). 18 
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Hydroxyproline Analysis 
For hydroxyproline measurements, tissue specimens were taken from the 
remaining part of the 3-cm 2 section of skin. The specimens were examined by 
an independent investigator who was blinded to their sources. Hydroxyproline 
levels (IJg/mg wet tissue) were measured by the spectrophotometric method 
described previously by Bergman and Loxley. 19 Briefly, the main principle of 
this method is to measure the optical density of the mixture which is composed 
of hydrolyzed wound tissue, chloramine T, hydrochloric acid, and Ehrlich re- 
agent at 560-nm wavelength. A Shimadzu 1202 spectrophotometer (Shimadzu 
Corporation, Kyoto, Japan) was used for hydroxyproline assessment. 
Tolerability 
In the literature, doses of E coli endotoxin defined as 1 to 10 mg/kg are sub- 
lethal doses and ___20 mg/kg are lethal doses in IP injections9,2°-22; in our setting 
we used a sublethal dose of 10 mg/kg. After a sublethal dose of endotoxin 
injection, symptoms of sepsis, such as increased nasal and ocular secretions, 
piloerection, and diarrhea might be seen in rats. 13 These symptoms usually 
resolve within 4 days after injection. However, previous studies have found 
that IV E coli endotoxin 10 mg/kg was associated with a mortality of ~50% within 
16 hours. 18,23 
Statistical Analysis 
Tensile strength measurements and tissue hydroxyproline l vels were ana- 
lyzed for all groups using the Kruskal-Wallis test. For individual group-to-group 
comparisons, the Mann-Whitney U test was used. The study was designed with 
a target number of 8 rats per group for statistical analysis. Statistical signifi- 
cance was defined as P < 0.05 for both tests. SPSS software, version 11.5 (SPSS 
Inc., Chicago, Illinois) was used for all statistical analysis. 
RESULTS 
Forty-four male Wistar albino rats (mean age, 16 weeks; mean [SD] weight, 
284 [16] g) were included in the study. Twelve rats were assigned to each of the 
3 groups that received endotoxin injections because of the possibility that some 
rats would die before the end of the study. The control group consisted of 8 rats. 
Hydroxyproline l vels in wound tissue followed the same pattern as tensile 
strength across the groups. The control group had the highest hydroxyproline 
levels, followed in descending order by the L-NIO group, the L-NAME group, and 
the endotoxin-only group (Table). Hydroxyproline l vels in the L-NIO group and 
the L-NAME group were significantly higher than in the endotoxin-only group 
(both, P < 0.001), but they did not differ significantly from each other. 
Mean (SD) wound tensile strength in decreasing order across the groups was 
as follows: control group, 298.27 (17.66) g/cm2; L-NIO group, 280.12 (14.38) g/cm2; 
L-NAME group, 241.38 (20.69) g/cm2; endotoxin-only group, 175.82 (18.73) g/cm 2 
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(Table). Tensile strength in the L-NAME group was significantly lower when 
compared with that of the control group (P = 0.001) but significantly higher 
than that in the endotoxin-only group (P < 0.001). Tensile strength in the L-NIO 
group was significantly higher than that in the endotoxin-only group (P < 0.001) 
and in the L-NAME group (P = 0.001) but did not differ statistically from that in 
the control group. 
The systemic sepsis induced by IP injection of E coli endotoxin was associ- 
ated with reductions in both mean tensile strength and mean hydroxyproline 
levels in wound tissue (Table). Following endotoxin injection, symptoms of 
sepsis (eg, increased nasal and ocular secretions, piloerection, and diarrhea) 
were observed in all rats, except for those in the control group. The symptoms 
were the most severe in the endotoxin-only group. These symptoms resolved 
within 24 hours in the L-NAME and L-NIO groups and within 72 to 96 hours in 
the endotoxin-only group. All rats returned to their normal activity and eating 
habits after the symptoms resolved. All rats survived up to the time they were 
euthanized. No unexpected adverse vents were observed. Although extra rats 
had been included as a safeguard in the groups receiving endotoxin injections, 
their survival was expected, because the endotoxin dose was nonlethal. 9 
DISCUSSION 
Under normal conditions cNOS produces the low levels of NO needed for 
wound healing, but under excessive inflammatory conditions iNOS is over- 
expressed and produces abnormally high amounts of NO. 9 The results of this 
controlled, experimental study were consistent with this, in that the rats in the 
endotoxin-only group had wounds with the lowest ensile strength and the low- 
est tissue levels of hydroxyproline. Based on our findings and those of previous 
studies, NO appears to be an important factor both in wound healing and in the 
regulation of collagen accumulation. 5,7,24-26 
In this study, inhibition of iNOS by a reversible inhibitor, L-NAME, was pro- 
tective against he decrease in hydroxyproline l vel and tensile strength. How- 
ever, L-NIO, an irreversible inhibitor of iNOS, prevented the decrease in hydroxy- 
proline levels and tensile strength more effectively than L-NAME in rats with 
systemic sepsis. 5,9 
The biologic activities of NO during the wound healing process include regu- 
lation of epithelization and vasodilatation. 27 The effects of inducing NO during 
sepsis and inflammation may be detrimental, depending on amount, duration, 
and anatomic site of synthesis. 28Inhibition of iNOS has been associated with 
restoration ofcollagen synthesis to a normal evel by restoring endothelial func- 
tion without affecting the overall inflammatory response. 1 In this study, we 
found that in the presence of endotoxin, hydroxyproline l vels in healing 
wounds were also improved when inhibitors of iNOS were used. 
Given the need for cNOS activity in normal wound healing and the adverse 
effect of iNOS activity in wound healing under excessive inflammatory condi- 
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tions, the iNOS/cNOS ratio might be an important  factor in wound healing in 
general. It can be expected that in condit ions such as sepsis, where excessive 
NO is produced by the activation of iNOS, the healing of incisional wounds will 
be impaired. This should be considered for the prevention of compl icat ions 
such as dehiscence or evisceration. The potential  clinical use of iNOS inhibitors 
in the regulation of wound NO synthesis and their ole in the mechan isms of 
wound healing are quest ions for further research. 
CONCLUSION 
Inhibition of NO synthesis may improve wound tensile strength, which suggests 
a possible role for NO inhibitors in improved wound healing in the presence of 
endotoxemia.  
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